Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bee Whisper is a specialized healthcare company focused on the field of apitherapy, utilizing honeybee-derived substances for therapeutic purposes. The company develops and markets a range of natural products, including ointments and creams formulated with high-quality bee venom, propolis, and royal jelly. Their primary focus is on providing non-invasive relief for chronic inflammatory conditions such as rheumatoid arthritis, osteoarthritis, and general muscle pain. By leveraging the bioactive properties of bee venom peptides like melittin, Bee Whisper aims to offer effective alternative treatments for pain management and dermatological health. The company operates internationally, distributing its Bulgarian-sourced bee products to a global market of health-conscious consumers and practitioners of alternative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bee Whisper Apitherapy.